Abstract:
The results of experimental studies concerned with the development of nano-sized drug delivery systems of antitumor drugs sarcolysin and melphalan are generalized. The structures and biological activities of nanocarriers in comparison with unmodified drugs are discussed. Particular attention is given to the liposomes containing lipid derivatives of sarcolysin and melphalan in the lipid bilayer.
Bibliography — 196 references.